Handelsinvest Investeringsforvaltning’s Array Biopharma Inc ARRY Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-219,535	Closed	-$10.2M	–	124
2019 Q2	$10.2M	Sell	219,535 -40,465	-16%	-$1.14M	2.14%	12
2019 Q1	$6.34M	Sell	260,000 -27,631	-10%	-$575K	1.4%	23
2018 Q4	$4.1M	Buy	287,631 +87,631	+44%	+$1.33M	1.02%	34
2018 Q3	$3.04M	Sell	200,000 -50,000	-20%	-$766K	0.62%	46
2018 Q2	$4.2M	Hold	250,000	–	–	0.92%	41
2018 Q1	$4.08M	Hold	250,000	–	–	0.91%	37
2017 Q4	$3.2M	Buy	250,000 +155,000	+163%	+$1.76M	0.71%	42
2017 Q3	$1.17M	Hold	95,000	–	–	0.27%	61
2017 Q2	$795K	Buy	+95,000	New	+$777K	0.2%	76

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's ARRY Position: Q3 2019 in Review

Handelsinvest Investeringsforvaltning sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 219,535 shares — an estimated $10.2M sold.

Handelsinvest Investeringsforvaltning first reported a position in ARRY in Q2 2017 and held it in 9 quarters. The position peaked at $10.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Handelsinvest Investeringsforvaltning reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 219,535 Array Biopharma Inc shares in Q3 2019, an estimated $10.2M.
Handelsinvest Investeringsforvaltning first reported a position in Array Biopharma Inc in Q2 2017 and held it in 9 quarters.
Handelsinvest Investeringsforvaltning's Array Biopharma Inc position peaked at $10.2M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q3 2019, filed 22 Oct 2019.